Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis

Bo Yao, Ruxin Zheng, Yabing Yang, Zhan Zhao, Gendie E Lash, Bihui Guo, Jinghua Pan, Hanlin Shuai, Hong Zhou, Minghua Wang, Ping Li
Cell reports. Medicine · 2025 · vol. 6(12) , pp. 102464 · doi:10.1016/j.xcrm.2025.102464 · PMID:41270735 · PMC12765842 · W4416432567
article OA: gold CC0 ⤵ 1 in-corpus citation
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study identifies activated IL-17C signaling, marked by increased IL-17RE expression and IL-17C levels, as a driver of endometriosis-associated ovarian carcinoma and demonstrates that targeting this pathway inhibits disease progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis-associated ovarian carcinoma (EAOC) predominantly arises from the malignant transformation of endometriomas, yet the mechanism is incompletely defined. Spatial transcriptomic analysis of human specimens of normal endometrium, endometriomas, and EAOC identified interleukin-17C (IL-17C) signaling activation, with higher IL-17 receptor E (IL-17RE) expression in EAOC. Additionally, the IL-17C concentration was significantly increased in the peritoneal fluid of women with ovarian cancer. Using an endometriosis mouse model overexpressing IL-17RE, IL-17C levels were elevated in the peritoneal fluid. Furthermore, IL-17C knockout reduced the peritoneal fluid IL-17C concentration and inhibited ectopic lesion growth in endometriosis mice. In addition, the role of IL-17C signaling in promoting endometriosis carcinogenesis was investigated by blocking and modulating the IL-17C/IL-17RE pathway in human endometriotic epithelial cells, endometrial organoids, and ovarian endometriosis mice. These data identified IL-17C signaling as a driver of endometriosis carcinogenesis and propose IL-17C/IL-17RE as promising therapeutic targets, particularly for EAOC cases characterized by high IL-17C expression.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Carcinogenesis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Interleukin-17

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (76)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-05-22T00:30:49.615688+00:00
License: CC0 · commercial use OK